Ireland:
IPHA Model Clinical Trial Agreement
10 December 2021
Arthur Cox
To print this article, all you need is to be registered or login on Mondaq.com.
On 2 November 2021, the Irish Pharmaceutical Healthcare
Association (“IPHA”), which represents
the international originator biopharmaceutical industry in Ireland,
published the initial draft of a model Clinical Trial Agreement
(“CTA”) for use between clinical trial
sites and sponsors in Ireland.
A draft of the CTA is available on the IPHA website. While the use of standardised
CTAs is commonplace in other jurisdictions, it is the first time a
model CTA has been published by an industry body in Ireland.
IPHA's aim in publishing the model CTA is to accelerate the
contractual negotiation process and reduce the divergence between
CTAs used by IPHA Member Companies and industry generally.
Following some feedback an updated version was published on 2
December 2021.
This article contains a general summary of developments and
is not a complete or definitive statement of the law. Specific
legal advice should be obtained where appropriate.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Ireland
Elderly Care FAQ
Wrigleys Solicitors
These FAQs cover topics related to caring for elderly relatives. It discusses how to place an elderly person in a care home, the absence of legal obligation for family members to provide long-term care...
Life Science Update: April 2024
Kromann Reumert
Welcome to this edition of Kromann Reumert's Life Science Update. In the following, we provide an overview of recent legal updates that will have a bearing on the life science industry across Europe...
Life Sciences 2024
Bär & Karrer
Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.